Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Placebo Effect01:54

The Placebo Effect

The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
Statistical Significance01:37

Statistical Significance

Once data is collected from both the experimental and the control groups, a statistical analysis is conducted to find out if there are meaningful differences between the two groups. A statistical analysis determines how likely any difference found is due to chance (and thus not meaningful). In psychology, group differences are considered meaningful, or significant, if the odds that these differences occurred by chance alone are 5 percent or less. Stated another way, if we repeated this...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic Modulation in Cancer Care: The Potential Role of Glucagon-Like Peptide-1 Receptor Agonists.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Prehabilitation for patients undergoing pelvic exenteration.

Surgical oncology·2026
Same author

Paediatric cervicomedullary perimedullary arteriovenous fistula presenting with intraventricular and subarachnoid haemorrhage: curative bilateral parallel-coiling.

BMJ case reports·2026
Same author

Management of Chronic Subdural Hematoma With Adjunctive Embolization of Middle Meningeal Artery: The EMMA-Can Randomized Clinical Trial.

JAMA·2026
Same author

Endovascular Acute Stroke Intervention-Tandem Occlusion (EASI-TOC) study: protocol and rationale.

European stroke journal·2026
Same author

Cerebral Hemodynamics Are Related to Cortical Brain Morphology in Heart Failure with Reduced Ejection Fraction Independent of Reduced Cardiac Output.

CJC open·2026
Same journal

Treatment of Coagulopathy.

Techniques in vascular and interventional radiology·2026
Same journal

Acute Kidney Injury for the Interventional Radiologist: A Review.

Techniques in vascular and interventional radiology·2026
Same journal

Acute Management of Dysrhythmias.

Techniques in vascular and interventional radiology·2026
Same journal

An Approach to Airway Management and Acute Respiratory Failure.

Techniques in vascular and interventional radiology·2026
Same journal

Emergency Preparedness in the Vascular and Interventional Radiology Suite-An Overview.

Techniques in vascular and interventional radiology·2026
Same journal

Management of Acute Hemorrhage and Damage-Control Resuscitation: Critical Care Concepts for Vascular Interventional Radiologists.

Techniques in vascular and interventional radiology·2026
See all related articles

Related Experiment Video

Updated: May 22, 2026

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
08:50

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants

Published on: December 14, 2014

Placebo power.

Katherine B Knox1, Michael E Kelly

  • 1Department of Physical Medicine and Rehabilitation, University of Saskatchewan, Saskatchewan, Canada. katherine.knox@saskatoonhealthregion.ca

Techniques in Vascular and Interventional Radiology
|May 30, 2012
PubMed
Summary
This summary is machine-generated.

The placebo response in multiple sclerosis (MS) trials, particularly for endovascular procedures, presents challenges. Understanding placebo effects is crucial for designing future MS studies.

More Related Videos

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
08:33

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on: January 5, 2024

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
11:51

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Published on: March 2, 2011

Related Experiment Videos

Last Updated: May 22, 2026

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
08:50

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants

Published on: December 14, 2014

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
08:33

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on: January 5, 2024

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
11:51

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Published on: March 2, 2011

Area of Science:

  • Neuroimmunology
  • Clinical Trial Design
  • Medical Ethics

Background:

  • Variable placebo responses are documented in multiple sclerosis (MS) and other sham surgery trials.
  • Conditioning and expectancy models offer biological explanations for placebo effects.
  • Neuroimmune mechanisms in MS may interact with placebo and treatment responses.

Purpose of the Study:

  • To address the scientific and ethical challenges of measuring placebo response in endovascular MS trials.
  • To highlight the potential for significant placebo responses in MS endovascular procedures.
  • To emphasize the need to consider placebo response factors in future study designs.

Main Methods:

  • Literature review of placebo response factors in MS and sham surgery.
  • Analysis of conditioning and expectancy models for placebo mechanisms.
  • Estimation of placebo response magnitude based on known influencing factors.

Main Results:

  • Placebo responses are variable and influenced by conditioning and expectancy.
  • Neuroimmune involvement in MS suggests complex interactions between placebo and treatment effects.
  • Significant placebo responses are anticipated for endovascular procedures in MS.

Conclusions:

  • Measuring placebo response in endovascular MS trials is scientifically and ethically complex.
  • Factors associated with larger placebo responses should be carefully considered.
  • Future studies investigating endovascular procedures for MS must account for potential placebo effects.